Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.

Cancer chemotherapy and pharmacology - 1 Jan 2014

Jakobsen Jan Nyrop, Santoni-Rugiu Eric, Sørensen Jens Benn

Abstract excerpt

INTRODUCTION: Class-III-beta-tubulin (TUBB3) expression may be a potential predictive factor for treatment with microtubule interfering cytotoxic drugs in non-small cell lung cancer (NSCLC). Potential changes in TUBB3 expression during chemotherapy may be of interest if future choice of chemotherapy is to be based on TUBB3 expression. If the biomarker expression changes during chemotherapy, biopsies before...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Longitudinal Studies

Share to Lung Neoplasms

Share to Lymphatic Metastasis

Share to Tubulin

Source

Identifiers

PMID: 24220933
DOI: 10.1007/s00280-013-2315-6

Genes

TUBB3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.PMID 24220933Read ↗

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.Semantic proximity Read ↗

Class III β-Tubulin in Advanced NSCLC of Adenocarcinoma Subtype Predicts Superior Outcome in a Randomized TrialSemantic proximity Read ↗

[Correlation between expression of TUBB3/STMN1 and EGFR signaling pathway in non-small cell lung cancer].Semantic proximity Read ↗

Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer.Semantic proximity Read ↗

<i>TUBB3</i> /βIII-Tubulin Acts through the PTEN/AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non–Small Cell Lung CancerSemantic proximity Read ↗

Analysis of beta-tubulin gene alteration in human lung cancer cell lines.Semantic proximity Read ↗

Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations.Semantic proximity Read ↗

Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.